These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9632039)

  • 21. Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: a case report.
    Chiou YJ; Lin PY; Lee Y
    Clin Neuropharmacol; 2015; 38(3):114-6. PubMed ID: 25970281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
    Salmerón JM; Alcántara AG; Barcia D
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature.
    Ke CL; Yen CF; Chen CC; Yang SJ; Chung W; Yang MJ
    Kaohsiung J Med Sci; 2004 Jun; 20(6):295-301. PubMed ID: 15253471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
    J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients.
    Bondolfi G; Eap CB; Bertschy G; Zullino D; Vermeulen A; Baumann P
    Pharmacopsychiatry; 2002 Mar; 35(2):50-6. PubMed ID: 11985287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
    Kim SW; Shin IS; Kim JM; Yang SJ; Hwang MY; Yoon JS
    J Clin Psychopharmacol; 2008 Jun; 28(3):349-52. PubMed ID: 18480697
    [No Abstract]   [Full Text] [Related]  

  • 27. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.
    Kopala L; Honer WG
    Am J Psychiatry; 1994 Nov; 151(11):1714-5. PubMed ID: 7524373
    [No Abstract]   [Full Text] [Related]  

  • 28. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
    Jacobsen FM
    J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of obsessive and depressive symptoms during risperidone treatment.
    Bakaras P; Georgoussi M; Liakos A
    Br J Psychiatry; 1999 Jun; 174():559. PubMed ID: 10616638
    [No Abstract]   [Full Text] [Related]  

  • 30. Obsessive-compulsive disorder presenting with gender incongruence obsessions.
    Uvais NA; Sreeraj VS
    Asian J Psychiatr; 2017 Dec; 30():77-78. PubMed ID: 28837942
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
    Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
    Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
    [No Abstract]   [Full Text] [Related]  

  • 32. Risperidone-induced obsessive-compulsive symptoms: serotonin-dopamine imbalance?
    Duggal HS
    J Clin Psychopharmacol; 2003 Dec; 23(6):681-2. PubMed ID: 14624209
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluoxetine Adjunctive Therapy for Obsessive-Compulsive Symptoms Associated With Olanzapine in Schizophrenic Patients.
    Figueiredo T; Segenreich D; Mattos P
    J Clin Psychopharmacol; 2016 Aug; 36(4):389-91. PubMed ID: 27285659
    [No Abstract]   [Full Text] [Related]  

  • 34. Sedative effects of low-dose risperidone in GAD patients and risk of drug interactions.
    Kopecek M; Mohr P; Novak T
    J Clin Psychiatry; 2006 Aug; 67(8):1307-8; author reply 1308-9. PubMed ID: 16965213
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluoxetine in Tourette's syndrome.
    Gatto E; Pikielny R; Micheli F
    Am J Psychiatry; 1994 Jun; 151(6):946-7. PubMed ID: 8185015
    [No Abstract]   [Full Text] [Related]  

  • 36. Deconstructing a medication regimen.
    Preskorn SH
    J Psychiatr Pract; 2008 Mar; 14(2):114-8. PubMed ID: 18360197
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction.
    Spina E; Avenoso A; Scordo MG; Ancione M; Madia A; Gatti G; Perucca E
    J Clin Psychopharmacol; 2002 Aug; 22(4):419-23. PubMed ID: 12172343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exacerbation of obsessive-compulsive symptoms associated with clozapine.
    Eales MJ; Layeni AO
    Br J Psychiatry; 1994 May; 164(5):687-8. PubMed ID: 7921724
    [No Abstract]   [Full Text] [Related]  

  • 39. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of schizophrenia with obsessive-compulsive features with serotonin reuptake inhibitors.
    Hwang MY; Martin AM; Lindenmayer JP; Stein D; Hollander E
    Am J Psychiatry; 1993 Jul; 150(7):1127. PubMed ID: 8100402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.